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Changes in synaptic physiology underlie neuronal network plasticity and behavioral phenomena, 
which are adjusted during development. The Drosophila larval glutamatergic neuromuscular junction 
(NMJ) represents a powerful synaptic model to investigate factors impacting these processes. Amino 
acids such as glutamate have been shown to regulate Drosophila NMJ physiology by modulating 
the clustering of postsynaptic glutamate receptors and thereby regulating the strength of signal 
transmission from the motor neuron to the muscle cell. To identify amino acid transporters impacting 
glutmatergic signal transmission, we used Evolutionary Rate Covariation (ERC), a recently developed 
bioinformatic tool. Our screen identified ten proteins co-evolving with NMJ glutamate receptors. 
We selected one candidate transporter, the SLC7 (Solute Carrier) transporter family member JhI-21 
(Juvenile hormone Inducible-21), which is expressed in Drosophila larval motor neurons. We show that 
JhI-21 suppresses postsynaptic muscle glutamate receptor abundance, and that JhI-21 expression in 
motor neurons regulates larval crawling behavior in a developmental stage-specific manner.
The glutamatergic Drosophila melanogaster larval neuromuscular junction (NMJ) is a powerful well-established 
model for the study of synaptic development and function. During the three larval stages the morphology of 
the NMJ changes dramatically1,2. From the hatching of a Drosophila larva up to the last larval instar, the muscle 
surface increases faster than the growth of the nerve terminals that innervate it. Despite this, the strength of 
these synapses is maintained at the same level3. This means that during larval development either the amount of 
released neurotransmitter or the receptivity of the muscle cell have to be adjusted. This could be achieved via a 
variety of mechanisms, including addition of new synapses to each junction, and changes in strength of individual 
synapses.
NMJ strength can also be tuned in previously unsuspected ways. In a previous study, for example, we identi-
fied a glial amino acid exchanger, Genderblind (GB), which is capable of tuning synaptic strength by regulating 
the amount of extracellular glutamate. This glutamate constitutively desensitizes ionotropic glutamate recep-
tors (iGluRs), inhibits their clustering, and thereby suppresses synaptic transmission4,5. We also showed that the 
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presynaptic neuron is capable of secreting non-vesicular glutamate through an unknown transporter to regulate 
NMJ strength by modulating iGluR clustering6.
In order to identify amino acid transporters that might regulate synaptic physiology during development, we 
used Evolutionary Rate Covariation (ERC). ERC is a recently established bioinformatic method that identifies 
functional relationships between proteins based on their evolutionary histories. The hypothesis of ERC is that 
functionally related proteins experience similar evolutionary selective pressures and hence have rates of evolu-
tion that correlate across species. ERC values are calculated by generating phylogenetic trees using full protein 
sequences and computing the correlation between the rates of change of two proteins across the branches of a 
phylogeny. The resulting values could range from 1 in case of positive correlation to -1 in case of negative cor-
relation (Fig. 1a)7. ERC has previously been used to study proteins that are physically interacting or present in 
the same protein complex8–12. However, recent studies demonstrated that functionally related and coexpressed 
genes reveal positive and significant ERC values as well7. In this study, we screened for transporters showing 
Figure 1. Evolutionary rate covariation. (a) The rates of evolution used in this study describe changes in 
protein sequences over time. To study if proteins are co-evolving, species trees were generated. In our study 
those trees were made by using homologue proteins of the following species: D.melanogaster, D. simulans, D. 
sechellia, D. yakuba, D. erecta, D. ananassae, D. pseudoobscura, D. persimillis, D. wilistoni, D. mojavensis, D. 
virillis and, D. grimshavi. The rates of a pair of proteins are plotted against each other and a factor is calculated 
describing the correlation of these rates. The rates of co-evolving proteins (protein A and B) are positive while 
proteins, which are not co-evolving (protein B and C) have correlation coefficients close to zero or negative. 
(b) As a positive control we calculated the global ERC value for the six glutamate receptors (mGluRA and 
iGluRA-E), which are known to act together at the Drosophila NMJ. For statistical analysis a mean correlation 
was calculated and compared to the mean correlation of random sets of six proteins. Next ERC values were 
calculated between the 39 transporter candidates and the GluRs mentioned above. Ten transporter candidates 
were showing robust ERC values (p < 0.05) with each glutamate receptor. Next we compared the expression 
pattern of the six GluRs with the expression pattern of the putative transporters. mGluR is predominantly 
expressed in the CNS, iGluRs in the carcass. Twelve putative transporters were showing their highest level of 
expression in either the CNS or the body wall (www.flybase.org), JhI-21 showed robust ERC with GluRs and 
was expressed highest in the same tissue than GluRs, and was chosen for further investigation. For statistical 
analysis the mean correlation of JhI-21 and the six GluRs was compared to a random groups of 7 proteins.
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evolutionary covariation with six glutamate receptor subunits. We hypothesized that the co-evolution of amino 
acid transporters and glutamate receptors might lead to the identification of unknown genes involved in glutama-
tergic signaling. We subsequently tested the functional relationship between those six GluRs and the transporters 
by taking advantage of the very well studied Drosophila larval NMJ physiology. Six GluRs have been shown to 
impact synaptic strength at this synapse: a metabotropic glutamate receptor subunit (mGluRA) expressed in 
motor neurons, and five iGluR subunits (GluRIIA, GluRIIB, GluRIIC, GluRIID, and GluRIIE) forming the iono-
tropic A- and B-type receptors expressed by the post-synaptic muscle cell13,14. We were particularly interested in 
transporters co-expressed with either mGluRA in motor-neurons or with iGluR subunits in muscle cells.
Using these criteria, we found a strong ERC value between these glutamate receptor subunits and the amino 
acid transporter JhI-21. Consistent with the idea that ERC predicts functional relationships, we found that JhI-21 
negatively regulates iGluR clustering at NMJs and plays a role in locomotion control during late larval devel-
opment. Investigating the reason for these effects, we discovered differential expression of JhI-21 in the central 
nervous system neurons and at the NMJ during larval feeding and wandering stages. Taken together, our results 
demonstrate how ERC can be used to find novel previously unsuspected roles for proteins, and reveal for the first 
time a role for JhI-21 in glutamatergic synapse function and behavior.
Results
JhI-21 is identified as a component of the glutamatergic signaling pathway by Evolutionary 
Rate Covariation (ERC). Six glutamate receptor subunits (mGluRA, GluRIIA-E) are known to be key 
members for signal transmission at the glutamatergic 3rd-instar larval NMJ. We identified their orthologs in 12 
Drosophila species and calculated their ERC values (Fig. 1b). The six glutamate receptors showed overall positive 
scores indicating robust rate covariation. The mean ERC value between all possible pairs of those 6 proteins is 
0.556 and is strongly significant (p = 0.00021, permutation test; Table 1). Positive ERC values are typically found 
for proteins acting as subunits in the same complex, as in the case for the ionotropic glutamate receptor subunits 
GluRIIA-E. Glutamate receptors in larval NMJs localize to postsynaptic densities on the surface of the muscle cell 
and always contain GluRIIC, GluRIID, and GluRIIE subunits. In addition, “A-Type” receptors contain GluRIIA 
while “B-Type” receptors contain GluRIIB. In contrast, the metabotropic mGluRA receptor subunit is expressed 
in the innervating motor neuron, and acts in a glutamatergic feedback loop regulating the amount of transmitter 
released15. Even though metabotropic and ionotropic glutamate receptors are not co-localized within the same 
cell at the NMJ of 3rd-instar larvae, they do act in the same intercellular signaling pathway and therefore the ERC 
values between the two different types of receptors are very high. These conditions demonstrate that ERC can 
detect proteins that function together despite being expressed in different cells. This finding enabled us to use this 
technique to screen for previously unrecognized candidate amino acid transporters associated with glutamatergic 
signal transmission.
In total, we first screened 39 confirmed and putative amino acid transporter homologs16,17 for rate covariation 
with the six glutamate receptors mentioned above (Table 2 and Supplemental Table1). Ten putative transporters 
showed positive and significant (p < 0.05) ERC values with the six glutamate receptor subunits (Table 2, Fig. 2). 
To prove the functional relationship between these GluRs and our positive hits we decided to focus next on the 
glutamatergic larval NMJ. The cell bodies of motor-neurons expressing mGluRA are located in the ventral nerve 
cord of the larval CNS. Those neurons project their axons towards the body wall where they contact muscle cells, 
which express iGluRs. Therefore, in parallel we used a second screening procedure to determine which transport-
ers are most highly expressed in either the CNS (where motor neuron cell bodies are housed) or the body wall 
(location of NMJs) (Tables 1 and 2). We found eleven putative transporter genes (Table 2, Fig. 2). We selected one 
significant hit from our ERC analysis, JhI-21, which also matched very well our second criterion concerning the 
expression pattern in the neuromuscular system (Fig. 2).
The single ERC values of JhI-21 compared to the different glutamatergic receptors range from 0.298 to 0.59 
(Supplemental Table 1). The global ERC value for JhI-21 and the six glutamate receptor subunits that we exam-
ined is 0.3788 (p = 0.0019, permutation test) (Table 2). This very high co-evolutionary statistic suggested that 
JhI-21 and the glutamate receptor subunits co-evolved and therefore may be functionally related.
Gene
ERC Data GluR expression pattern




GluRIIA XX X X




Table 1.  Glutamate receptors show overall positive ERC values and highest expression in the CNS or the 
body wall. The table shows the grouped ERC value of all six glutamate receptors together and its corresponding 
p-value. The positive ERC value indicates the strenght of evolutionary covariation between all 6 GluRs. The 
larval expression pattern of the glutamate receptors according to Flyatlas (www.flybase.org) is summarized 
as followed: X = low expression (10 – 99), XX = moderate expression (100 – 499). Tissues are abrevated as 
followed: central nervous system (CNS), digestive system (DS), malpighian tubules (MT).
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JhI-21 was initially discovered in a screen for juvenile hormone (JH) inducible genes18,19. It was classified 
as a SLC7A5-11 family member based on sequence analysis4, and amino acid uptake into cultured cells20. The 
Drosophila genome encodes four more putative SLC7A5-11 paralogs: Genderblind (GB), Minidiscs (Mnd), 
CG9413 and CG16074,20. GB controls extracellular glutamate levels, which in turn regulates the number of iGluRs 
in the glutamatergic NMJ4,21. This unexpected function -regulation of iGluRs in synapses- was recently shown to 
be also conserved in mice22.
We therefore turned our attention to testing explicitly whether JhI-21 and iGluRs in the Drosophila are func-
tionally related, as predicted by ERC.
Transporter
ERC Data Transporter expression pattern
ERC value p-value CNS Body wall DS MT Fat body Trachea
bdg 0.465 0.0001 X X X X X X
CG8785 0.3828 0.0007 XXXX XX X
CG13384 0.4405 0.0007 XX XX XX XX XXX XX
JhI-21 0.3788 0.0019 XXX XX XX X X XX
CG16700 0.4073 0.0023 X XX XX X X
CG9413 0.305 0.0028 XX XXX XXXX X X
CG7255 0.4127 0.0045 X X X X
DAT 0.3223 0.0075 X
mnd 0.2603 0.0122 XX XX X XX X X
CG13795 0.23 0.0467 X X X XXXX
blot 0.183 0.0624 XX XXX XX XX X XXX
ine 0.1678 0.0737 X X XXXX XX
gb 0.1493 0.1334 XXX X XX X XXX X
CG1698 0.1077 0.2114 X XXX X X
CG32079 0.107 0.2472
VGlut 0.0648 0.2617 X
CG43066 0.0193 0.4055
SerT 0.0298 0.4108 X X
CG5535 0.0737 0.4433 XX XX XX X X XX
CG4476 − 0.0002 0.597 XX X
CG15279 − 0.0185 0.6095 XX X XXXX XX
CG13796 − 0.0432 0.6126 X XX XX X XXXX XX
CG4991 − 0.063 0.7208 X XX X
CG12531 − 0.072 0.600
NAAT1 − 0.0828 0.739 XX XX
Eaat1 − 0.087 0.74 XXX XX X XX
path − 0.0598 0.797 XXX XX XX X XX X
CG5549 − 0.1158 0.8007
slif − 0.1537 0.9087 XX XXX XXXX X
CG7888 − 0.1735 0.929 XX X XXX
Vmat − 0.1715 0.9422 XXX XX
CG8850 − 0.227 0.9604 X XXX XXX
CG15088 − 0.2275 0.9631 X X XX
CG1139 − 0.2303 0.9736 XXX X XXX X
VGAT − 0.2725 0.9929 X
CG1607 − 0.3837 0.9988 XXXX XX XX XX XXX XX
CG13248 − 0.434 0.9998 XX X
CG10804 − 0.435 0.9999 XX
Eaat2 − 0.5347 1.00 XXX
Table 2.  Co-evolution of putative transporter genes with glutamate receptors and summary of their larval 
expression pattern. The table shows group ERC values of 39 putative amino acid transporters and glutamate 
receptor subunits (mGluRA, GluRIIA, GluRIIB, GluRIIC, GluRIID, and GluRIIE) with their corresponding 
p-values. The magnitude of positive ERC values indicate the strength of evolutionary covariation between the 
amino acid transporter and the 6 GluRs. The expression pattern according to Fly Atlas (www.flybase.org) is 
summarized as followed: X = low expression (10 – 99), XX = moderate expression (100 – 499), XXX = high 
level expression (500 – 999), XXXX = very high expression (> 999). Tissues are abrevated as followed: central 
nervous system (CNS), digestive system (DS), malpighian tubules (MT).
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JhI-21 is expressed in motor neurons at the glutamatergic NMJ of 3rd instar larvae. We first 
investigated whether JhI-21 is expressed at the larval neuromuscular junction close to the glutamate receptor 
subunits with which ERC revealed it to coevolve. The Drosophila larval NMJ is a tripartite synapse containing the 
presynaptic motor neuron, the postsynaptic muscle cell, and adjacent glia. All three cell-types are known to be 
involved in regulating synaptic development and physiology23. First, we designed a polyclonal anti-JhI-21 anti-
body and confirmed its specificity in JhI-21 null mutant embryos (Figure S1). As shown in Fig. 3a, we could detect 
the anti-JhI-21 labeling at the NMJ. This anti-JhI-21 signal co-localized with the anti-HRP, which marks presyn-
aptic motor terminals. These data therefore strongly suggest that JhI-21 is expressed in motor neuron terminals.
However, the close proximity of different cell types (neurons, muscle, or glia) at the NMJ makes it difficult to 
conclude cell-type expression based on light microscopy alone. To address this problem, we generated transgenic 
flies in which Gal4 is expressed under the control of a putative JhI-21 regulatory region, and then examined the 
expression pattern of UAS-nSyb::GFP using the Gal4/UAS system24 (Fig. 3b). Synaptobrevin (Syb) is a synaptic 
terminal protein, and therefore nSyb::GFP will be enriched at synaptic endings when expressed in neurons25. 
Consistent with the conclusion that JhI-21 is expressed in motor neurons, nSyb::GFP expressed under control 
of JhI-21-Gal4 was localized to synaptic terminals. To ensure that nSyb::GFP did not localize similarly when 
expressed in glia or muscles, we also expressed nSyb::GFP under the control of well-characterized glial and mus-
cle cell Gal4 drivers (repo-Gal4 and 24B-Gal4, respectively; Fig. 3c,d). As expected, the nSyb::GFP fluorescence 
pattern in these cases was drastically different from when nSyb::GFP is expressed in motor neurons. We therefore 
conclude that JhI-21 is normally expressed in motor neurons and (based on antibody staining) at least in part 
localized to motor neuron terminals.
To determine whether JhI-21 was expressed in other parts of the motor neurons, we examined the expres-
sion of JhI-21 protein in the ventral nerve cord (VNC), and compared it to the location of glutamatergic motor 
neurons cell bodies marked using the OK6-Gal4, which is expressed in motor neurons, or OK371-Gal4, which 
is expressed in glutamatergic neurons, using membrane-bound GFP (mCD8::GFP) as a reporter transgene. As 
shown in Fig. 3e, anti-JhI-21 labeling was detected in cell bodies at the VNC. While most neurons appear to 
express low levels of JhI-21, some neurons identified as a subset of glutamatergic motor neurons by the OK6-Gal4 
or OK371-Gal4 driven expression of mCD8::GFP, express JhI-21 at a higher level (solid arrow in Fig. 3e; white 
bordered arrow in Fig. 3f). According to the results obtained with our anti-JhI-21 antibody and our JhI-21-Gal4 
transgene, JhI-21 seems to be expressed in neurons of 3rd-instar larvae, with highest expression in motor neurons 
(Fig. 3, Figure S2). However, our JhI-21-Gal4 transgene recapitulates just partially the endogenous expression of 
JhI-21 expression in the brain (Figure S2), suggesting that JhI-21 expression in motor neurons may be variable 
or actively regulated.
Loss of JhI-21 expression increases iGluR clustering in NMJs. The expression pattern of JhI-21, along 
with its co-evolution with glutamate receptors, raised the possibility that JhI-21 regulates NMJ physiology. To test 
this hypothesis, we performed two-electrode voltage-clamp electrophysiology to measure spontaneous excitatory 
junction currents (sEJCs) in control and JhI-21 mutant larval NMJs (muscle 6, segment A3). We used the hypo-
morphic JhI-21 allele P{SUPor-P}JhI-21[KG00977], (hereafter referred to as ‘JhI-21 KG’), which was generated by 
the BDGP Gene Disruption Project and carries a P{SUPor-P} transposable element in the first exon of the JhI-21 
gene26. The JhI-21 KG allele was used homozygous or in combination with a deficiency (Df1 is Df(2L)esc-P3-0), in 
which the JhI-21 gene is deleted27. Another strain, PJhI-21[EP1187] (JhI-21 EP), contains UAS-binding sites and 
was used to over-express JhI-2128. As controls, we used w1118 (control 1) and P*82 (control 2). P*82 is a clean exci-
sion allele of the JhI-21 P-element [KG00977] (Fig. 4a)29. As shown in Fig. 4d, sEJC amplitudes are strongly cor-
related with JhI-21 expression as measured by q-PCR. sEJC amplitude distributions measured in the two control 
strains are nearly indistinguishable from each other (P > 0.05, n.s., Kolmogorov-Smirnov test). The JhI-21 hypo-
morphs, however, display significantly larger spontaneous postsynaptic currents (P < 0.05). In contrast, larvae 
overexpressing JhI-21 show smaller postsynaptic currents (P < 0.01 compared to control 1; Fig. 4b,c; Figure S3).
sEJC frequencies were not significantly different between genotypes (control 1 = 2.6 ± 0.5 Hz; control 
2 = 2.3 ± 0.3 Hz; JhI-21 KG = 1.9 ± 0.2 Hz; JhI-21 KG/Df1 = 2.5 ± 0.3 Hz; tub-Gal4/JhI-21 EP = 1.7 ± 0.3 Hz; 
n.s.) ruling out the possibility of changes in presynaptic release.
Figure 2. Candidate amino acid transporters involved in glutamatergic transmission. The Drosophila 
genome encodes 39 genes showing homology to amino acid transporters4,44. 10 of those were predicted to be 
co-evolving with GluRs by usage of ERC (blue) (ERC-values > 0.23 and p < 0.05). Out of those 39 putative 
transporter genes 11 show the highest level of expression in the same tissue as either mGluRA (highest 
expression in the CNS) or iGluRs (highest expression in the body wall) (green). We picked one candidate gene, 
JhI-21, for further analysis.
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As expected based on changes in sEJC size, overexpression of JhI-21 in the JhI-21 EP strain led to a reduction 
in evoked excitatory junction currents (eEJCs; Figure S4). This suggests that increased JhI-21 leads to less muscle 
excitation. However, we observed no significant differences between the controls and loss-of-function mutant 
genotypes (Figure S4).
The number of NMJ branches, number, and bouton area were not statistically different in between controls 
and JhI-21 mutant alleles (Fig. 4e).
The dramatic changes in sEJC amplitude without apparent changes in NMJ morphology or frequency 
of neurotransmitter release suggest that JhI-21 mutant NMJs might cause alterations in the number of 
Figure 3. JhI-21 is expressed in presynaptic motor nerve terminals. (a) Confocal image of third-instar 
larval NMJ formed on ventral longitudinal muscles 6 and 7 marked by anti-HRP (magenta) co-stained with 
antibodies against JhI-21 (green). (b–d), Representative confocal projections of third-instar larval NMJs formed 
on ventral longitudinal muscles 6 and 7, stained with antibodies against HRP (magenta) and against GFP 
(green). Only JhI-21-Gal4 driven transgenic synapse-tethered GFP (nSyb::GFP) expression co-localizes with 
anti-HRP labeling (B). Glial (repo)-Gal4 or muscle (24-B)-Gal4 driven nSyb::GFP does not show co-localization 
with anti-HRP labeled motor-neurons. (e,f) Ventral nerve cord (VNC) of third instar larva. (E) Cell bodies 
of motor-neurons marked by OK6-Gal4 driving the expression of membrane bound mCD8GFP (green), and 
are co-labeled by anti-JhI-21 (magenta). (F) Cell bodies of glutamatergic neurons marked by OK371-Gal4 
driving the expression of membrane bound mCD8GFP (green), and are co-labeled by anti-JhI-21 (magenta). 
Two arrowheads are pointing two examples of cells expressing both the GFP marker and JhI-21. Scale Bar 
NMJ = 20 mm. Scale Bar VNC = 40 μ m.
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postsynaptic glutamate receptors. To test this, we measured postsynaptic glutamate receptor protein abundance 
immunohistochemically.
Drosophila muscle cells express two different subtypes of heterotetrameric iGluRs, called ‘A-type’ and ‘B-type’, 
which can be distinguished immunocytochemically using antibodies against the subunits unique to each receptor 
type: GluRIIA, and GluRIIB30–33.
Figure 4. The electrophysiological response at the muscle 6/7 NMJ is controlled by JhI-21. (a) Schematic 
representation of the JhI-21 genomic locus. Exons are indicated by boxes, translated exons of the JhI-21 gene 
by black boxes, 5´and 3´untranslated regions of the JhI-21 gene as gray boxes. Triangles represent the inserting 
region of P-elements used to generate hypo-(stripped triangle) or hypermorph (grey triangle) JhI-21 alleles. 
(b) Representative traces for two-electrode voltage clamp experiments from the larval muscle 6 (LIII). As 
wildtype we used w1118 (control 1) and a clean excision of P(KG00977) (control 2). (c) Relative cumulative 
frequency histogram of sEJC (“mini”) amplitudes from different genotypes in third-instar Drosophila larvae. 
Rightward shift (JhI-21 KG and JhI-21 KG/Df1, blue) indicates increase in the abundance of current-conducting 
postsynaptic receptors, i.e larger synaptic currents. Note the shift to the left (i.e. decreased receptor number) in 
JhI-21 overexpression mutants (gray) N = 6-10 animals, 800-3.400 events measured. Kolmogorov-Smirnov test 
was used to compare the cumulative distributions two by two (*P < 0.05; **P < 0.01). (d) Negative correlation 
between the JhI-21 mRNA levels and the number of sEJC amplitudes at the NMJ. (e) Motor neurons were 
stained using anti-HRP and confocal images were taken at the 6/7 NMJ. Neither JhI-21 KG nor JhI-21 KG/Df1 
showed alterations of synaptic morphology in terms of NMJ branches, bouton number, or bouton area using a 
Kruskal-Wallis test. Error bars represent SEM in d and e.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:19692 | DOI: 10.1038/srep19692
Using anti-GluRIIA and anti-GluRIIB antibodies, we compared the immunoreactivity for both A- and B-type 
receptors in wild-type controls and in the JhI-21 alleles. The strongest JhI-21 hypomorph allele (JhI-21 KG/Df1) 
causes a ~5-fold increase in the postsynaptic receptor abundance for A-type receptors and a ~3.5-fold increase 
in B-type receptors compared to control. In contrast, overexpression of JhI-21 (tub-Gal4/JhI-21 EP) caused a 
significant decrease in A- and B-type receptors compared to control genotypes at the NMJ (Fig. 5). We obtained 
the same effect when looking at the GluRIIC subunit, which is shared by A- and B-type receptors (Fig. 6). Overall, 
as observed for sEJC amplitudes, the iGluR immunoreactivity was negatively correlated to the amount of larval 
JhI-21 mRNA detected by q-PCR (Fig. 5). Taken together, these results show that JhI-21 negatively regulates glu-
tamatergic transmission and the abundance of iGluR protein at the larval NMJ.
We next wondered if the action of JhI-21 on iGluR clustering could be through the action of glutamate, based 
on previous work showing that the related transporter GB controls iGluR abundance via regulation of extra-
cellular glutamate4,5. Consistent with this idea, we could fully rescue the phenotype of our strongest mutant 
by bathing JhI-21 KG/Df1 NMJs with 2 mM glutamate during 24 h when measuring GluRIIC staining (Fig. 6). 
Unfortunately our intense efforts to test if JhI-21 could transport (or not) glutamate, by glutamate quantification 
in the hemolymph or by using the S2 cell model system, failed to give conclusive results (Figure S7).
JhI-21 regulates locomotor behavior. Our results reveal JhI-21 as an unexpected regulator of NMJ iGuR 
abundance and spontaneous synaptic transmission strength. But what role does this novel form of regulation 
play ? To test whether changes in JhI-21 expression at the NMJ and/or in the CNS could have behavioral con-
sequences we measured speed and meandering (turning rate) at two different physiological stages of 3rd-instar 
larvae: feeding and wandering (shortly before pupation).
In the absence of food, wildtype feeding-stage larvae moved significantly faster than wildtype wandering-stage 
larvae (0.093 ± 0.003 cm/sec, and 0.070 ± 0.003 cm/sec respectively; p < 0.0001). Also, feeding-stage larvae had 
Figure 5. Postsynaptic glutamate receptor immunoreactivity is inversely proportional to JhI-21 expression 
levels. Genotypes used are the same than the ones shown in Fig. 2. (a) Left, representative confocal images 
showing the accumulation of GluRIIA receptor subunits at the NMJ in JhI-21 hypomorphs (JhI-21 KG/Df1) 
compared to a control genotype control 2; middle, quantification of the NMJ GluRIIA and GluRIIB abundance 
in various genotypes; right, negative correlation between the JhI-21 mRNA levels and the abundance of type-A 
glutamate receptor subunits at the NMJ. (b) Immunohistochemistry of type B glutamate receptor subunits 
(GluRIIB) shows similar (negative) correlation with JhI-21 transcript levels (N = 4–13 animals). Error bars 
represent SEM; statistical test: Kruskal-Wallis test. (*p < 0.05; **p < 0.01; ***p < 0.001).
www.nature.com/scientificreports/
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a lower turning rate compared to the wandering-stage larvae (1651 ± 151 deg/cm for feeding-stage larvae com-
pared to 2918 ± 335 deg/cm for wandering ones; p < 0.01; Fig. 7a,b).
To test whether JhI-21 regulates locomotor behavior, we used the hypomorphic JhI-21 KG allele. Wandering 
homozygous JhI-21 KG hypomorphs still showed a significant decrease in speed (from 0.078 ± 0.003 cm/sec in 
feeding stage to 0.066 ± 0.003 cm/sec in wandering stage; p < 0.05), but no change in meandering (2263 ± 210 
deg/cm in feeding stage versus 2677 ± 269 deg/cm in wandering stage; n.s.). In the strongest viable mutants, JhI-
21 KG/Df1 hypomorphs, neither speed (0.083 ± 0.003 cm/sec in feeding stage and 0.081 ± 0.003 cm/sec in wan-
dering stage) nor meandering (2685 ± 331 deg/cm in feeding stage and 2126 ± 195 deg/cm in wandering stage) 
differed between feeding and wandering larvae (Fig. 7a,b; Figure S5). Therefore, JhI-21 mutants do not exhibit 
normal differences between feeding and wandering larvae in locomotor characteristics (speed and meandering) 
that are displayed by control animals.
To confirm the association between JhI-21 expression level and locomotor behavior, we divided within each 
genotype the mean value scored for feeding animals by the mean value scored for wandering animals, and plotted 
this ratio against the average JhI-21 mRNA levels. The ratio for speed negatively correlates with JhI-21 mRNA 
levels, while the ratio for meandering positively correlates with the expression levels of JhI-21 mRNA (Fig. 7a,b).
We also looked at other locomotor phenotypes such as the number of stops and go, and the peristaltic waves 
along the length of the larval body axis. No difference between feeding and wandering larvae were found (Figure S6). 
Since all genotypes tested in this assay showed also no difference in developmental time or lethality (Fig. 7c), 
JhI-21 expression at the NMJ and/or in the CNS seems to specifically regulate locomotor behavior shifts (speed 
and meandering) that normally occur in late 3rd-instar larvae.
Synapse physiology differs in feeding and wandering 3rd-instar larvae. If JhI-21 regulates NMJ 
physiology, and this regulation affects feeding and wandering behavior, then there should be differences in NMJ 
physiology between feeding and wandering larvae. To test this, we compared sEJC amplitude distributions in 
feeding and wandering animals. In our control genotype we observed overall smaller amplitudes of sEJCs when 
larvae were in the wandering stage compared to feeding stage larvae (p< 0.0001). This change could be explained 
by JhI-21-mediated inhibition of iGluR clustering at the postsynaptic muscle cell during the wandering stage 
(Fig. 4). To test this hypothesis explicitly, we compared sEJCs in our strongest JhI-21 hypomorph (JhI-21 KG/
Df1). The JhI-21 hypomorphs exhibit overall larger spontaneous miniature postsynaptic currents in wandering 
stage compared to feeding 3rd-instar larvae, consistent with the hypothesis (p< 0.001; Fig. 8).
JhI-21 is differentially expressed in feeding and wandering 3rd-instar larvae. How does JhI-21 
regulate feeding and wandering behavior? One possibility is that JhI-21 expression at the NMJ, and thus the 
strength of NMJ regulation, differs between feeding and wandering stages. To test this we stained the nervous 
system of feeding and wandering 3rd instar larvae with the anti-JhI-21 antibody and analyzed the expression 
levels. In the VNC, where the cell bodies of motor neurons are located, expression of JhI-21 is significantly 
higher in feeding animals than in wandering ones (feeding stage 1.275 ± 0.266, wandering stage 0.531 ± 0.117; 
p < 0.05) (Fig. 9a–c). The anti-Bruchpilot antibody nc82 labels the neuropil34 and was used as an internal con-
trol for this experiment. As shown in Fig. 9d, the signal obtained with nc82 was constant between feeding-stage 
(94 ± 6) and wandering-stage larvae (107 ± 10). In contrast JhI-21 staining could never be detected at the NMJ 
of feeding-stage animals, but wandering stage animals showed strong anti-JhI-21 labeling in the NMJ (Fig. 9e,f). 
Thus, JhI-21 subcellular localization appears to shift between feeding and wandering stages. During feeding stage, 
Figure 6. Postsynaptic GluRIIC immunoreactivity is dependent on JhI-21 expression and ambient 
glutamate. Bar graphs showing postsynaptic GluRIIC abundance in a control genotype (precise excision of 
JhI-21 P[KG00977]) and a JhI-21 hypomorph allele JhI-21 KG/Df1, and showing postsynaptic reduced GluRIIC 
abundance in JhI-21 KG/Df1 mutants incubated with 2 mM ambient glutamate or without for 0h or 24 hours. 
(N = 3-6 animals per genotype and condition). *p < 0.05 (control compared to the other incubation times 2 by 2); 
**p < 0.01; ns: not significant (Mann-Whitney tests). Error bars represent SEM.
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JhI-21 is predominantly in the cell bodies within the VNC and not in the motor terminals. During wandering 
stage, JhI-21 is strongly localized in the motor terminals at the NMJ, and less abundant in the cell bodies within 
the VNC.
Discussion
Evolutionary rate co-variation identified JhI-21 as a member of glutamatergic signaling. In 
this study we used the “covariation of protein evolutionary rates” to screen for proteins that might play unsus-
pected roles in glutamatergic synapse physiology. It has been previously demonstrated that ERC signatures pro-
vide a powerful method to reveal functionally related proteins or proteins acting in the same complex8,35,36. As 
expected, physically interacting ionotropic glutamate receptor (iGluR) subunits GluRIIA, GluRIIB, GluRIIC, 
Figure 7. JhI-21 mutants lack age-dependent shift in locomotor behaviors. (a,b) Parameters of locomotion 
were analyzed in wildtype larvae (control 1, w1118) and JhI-21 mutants (JhI-21 KG and JhI-21 KG/Df1). (a) right, 
Speed is significantly decreased in wandering wildtype larvae compared to feeding individuals. ****p < 0.0001. 
This difference is still present, although reduced in JhI-21 KG mutants. *p < 0.05. Difference in speed between 
feeding and wandering larvae is not present in JhI-21 KG/Df1 mutants. Left, the ratio of average speed of feeding 
larvae/average speed of wandering larvae correlates with JhI-21 mRNA levels. (b) right, the meander describes 
amount of turnings in degree per cm and was used to characterize the turning behavior. 3rd instar wildtype 
larvae increase their average turning in wandering stage. **p < 0.01. Neither JhI-21 KG nor JhI-21 KG/Df1 
mutants show a significant change in turning behavior between both 3rd-instar larval stages. Left, the ratio of 
average meander of feeding larvae/average speed of wandering larvae shows negative correlation with JhI-21 
mRNA levels. (c) JhI-21 mutants show no difference in lethality or developmental time as compared to the 
control genotype. Statistical test in (a,b): 2-Way-ANOVA, N = 30, Error bars represent SEM. Statistical test in c 
Mantel-Cox test: N = 131-334 per genotype.
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Figure 8. The age-dependent shift in electrophysiological response at the muscle 6/7 NMJ is controlled by 
JhI-21. Cumulative frequency histograms of sEJC (“mini”) amplitudes from third-instar feeding and wandering 
Drosophila larvae. Leftward shift in wandering control animals indicates an age-dependent decrease in the 
abundance of current-conducting postsynaptic glutamate receptors, i.e smaler synaptic currents. This shift is 
inverted to rightward in the JhI-21 KG/Df1 allele. N = 4–5 animals (representing 10–17 NMJs), 2400–3600 
events measured per phenotype; Statistical test: Kolmogorov-Smirnov test (***P < 0.001, ****P < 0.0001).
Figure 9. JhI-21 is differentially expressed in the nervous system of feeding and wandering 3rd-instar 
control larvae. (a,b) Confocal projection of w1118 3rd-instar larval VNC stained with anti-JhI-21 (magenta) and 
NC82 antibody (green). (c,d) Quantification of signal intensity reveals higher expression of JhI-21 in the ventral 
nerve cord of feeding larvae compared to wandering ones (**p < 0.01, N = 12, Mann Whitney test). Intensity of 
nc82 does not change between these larval stages (N = 12, unpaired t-test). (e,f) Confocal images of third-instar 
larval (LIII) NMJs of muscles 6 and 7, stained with antibodies against HRP (stains all neuronal membrane, 
green) and JhI-21 (magenta). At the NMJ anti-JhI-21 labeling is detectable at wandering stage, not at feeding 
stage. Scale Bar (brains) = 40 mm. Scale Bar (NMJs) = 20 mm. Error bars represent SEM in c and d.
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GluRIID, and GluRIIE showed overall positive ERC values. Even if the metabotropic glutamate receptor mGluRA 
is neither physically interacting nor co-expressed in the same cell than iGluR subunits, it also showed positive 
ERC values when compared to iGluR subunits, likely due to its action in the same neurophysiological pathway. 
We therefore considered whether the function of two proteins in the same synapse can be sufficient to gain posi-
tive ERC values even though both the proteins are not expressed in the same cell.
We next used ERC to determine whether any of 39 putative amino acid or biogenic amine transporters genes 
were co-evolving with GluRs, and got 10 significant hits. Based on ERC scores and tissue expression, we selected 
the amino acid antiporter JhI-21 for further analysis. Specifically, we sought to determine whether JhI-21 did 
indeed function in the glutamatergic signaling pathway as suggested by ERC.
Using two independent strategies we showed that JhI-21 is localized in glutamatergic motor neurons in 
3rd-instar larvae. JhI-21 showed the strongest correlation in terms of co-evolution with mGluRA, which is also 
expressed in motor neurons15. Although co-expressed proteins tend to have higher ERC values in general7, we 
want to highlight that JhI-21 also showed positive ERC score with the post-synaptically expressed iGluRs, indi-
cating a previously unsuspected but important role for JhI-21 in adjusting the strength of glutamatergic neuro-
muscular transmission.
Interestingly, other significant hits are not even expressed in the CNS or the body wall. For example CG8785 
is expressed only in the digestive system and malpighian tubules. Both tissues also contain iGluRs. What might 
be the role of iGluRs in the digestive and Drosophila renal system and what could be the link to the co-evolution 
with CG8785 is an interesting subject for further studies.
Possible direct action of JhI-21 in adjusting synaptic strength at the larval NMJ. The fact that 
JhI-21 is expressed at the glutamatergic synapse allowed us to further elucidate the functioning of the NMJ in 
Drosophila. Specifically, we found that JhI-21 expression in motor neurons leads to inhibition of synaptic trans-
mission by reducing the clustering abundance of iGluRs in neuromuscular junctions of late stage 3rd-instar lar-
vae. This could be linked to the extracellular glutamate concentration since additional application of glutamate 
can compensate a lack of JhI-21 activity in JhI-21 hypomorph mutants when measuring the amount of iGluR 
expression at the NMJ (Fig. 6). It is therefore reasonable to ask whether JhI-21 has a direct impact on extracellular 
glutamate levels at the NMJ.
Indeed JhI-21 was classified as a SLC7A5-11 family member based on sequence analysis4. These transporters 
can be found in many species across the animal kingdom and other members of this transporter family have been 
proven to regulate glutamatergic signaling directly by adjusting extracellular glutamate levels in mammals and 
Drosophila4,20. This extracellular glutamate is mostly independent of synaptic vesicular release6,37,38, and is partly 
attributable to glial expressed SLC7A11 transporters4,21,39. Those transporters in mammals act as hererodimers 
consisting of a ‘light chain’ SLC7A5-11 core catalytic subunit in combination with a ‘heavy chain’ subunit (such 
as 4F2hc protein) that is required for trafficking to the plasma membrane40–43. GB, which is the homologue of 
JhI-21, previously revealed to be expressed in a particular subset of glia at the larval NMJ, was the first Drosophila 
SLC7A5-11 member shown to directly impact the physiology of this glutamatergic synapse by exporting gluta-
mate into the hemolymph4,44. This led us speculate that JhI-21 might also export glutamate directly. Nevertheless, 
when compared to GB, JhI-21 does not affect the overall hemolymph glutamate concentration29. Presumably, JhI-
21 modulates postsynaptic iGluR levels via some other mechanism, or regulates glutamate only very locally near 
the synapse, in contrast to GB, which controls glutamate levels more globally (Fig. 10). Using JhI-21 expressing 
Figure 10. JhI-21 co-evolved with glutamate receptors, and regulates strength of glutamatergic signaling 
at the larval NMJ. JhI-21 is expressed in motor neurons together with mGluRA, and regulates synaptic strength 
by inhibiting the clustering of iGluRs at the postsynaptic muscle cell specifically during the wandering stage in 
third-instar larvae. The schematic representation illustrates two possible functions of JhI-21 on iGluR clustering 
in wandering larvae. On the left is shown the direct export of glutamate close to the synapse, which inhibits 
iGluR clustering. On the right, an indirect action of JhI-21 is proposed through the transport of leucine. Leucine 
acts on the activity of the Glutamate dehydrogenase (Gdh), which can reciprocally catalyze the production 
of a-ketoglutarate (a-KG) to glutamate within the motoneuron. Glutamate then could be released to the 
hemolymph surrounding the NMJ via an unidentified transporter, and act on iGluR clustering.
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S2 cell we could not demonstrate that this transporter might directly or not transport glutamate (Figure S7), 
although we found that incubating larval NMJs in glutamate was able to rescue the JhI-21 phenotype (Fig. 6).
We also considered whether JhI-21 might be involved in loading glutamate into neurotransmitter vesicles and 
might thereby have a direct impact in glutamatergic transmission. No SLC7A5-11 family member is known to be 
a component of synaptic vesicle membrane. Also it has been shown that at the larval NMJ the vesicular glutamate 
transporter (VGlut, belonging to the SCL17 family) is necessary and sufficient to fill vesicles with glutamate. 
Absence of VGlut leads to empty vesicles at the NMJ45. This indicates that there is no other transporter involved 
in the filing of glutamate into these neurotransmitter vesicles.
Possible indirect action of JhI-21 in adjusting synaptic strength at the larval NMJ. It has been 
previously shown that non-vesicular glutamate release is partially dependent on the amount of glutamate pres-
ent in the motor neuron6. This intracellular glutamate pool is regulated via glutamate metabolizing enzymes. 
Glutamate oxaloacetate transaminase (GOT) produces glutamate from aspartate. Glutamate decarboxylase 
(GAD) catalyzes the decarboxylation of glutamate to γ -aminobutyric acid (GABA), and glutamate synthase (GS) 
converts glutamate to glutamine4,44. In addition glutamate dehydrogenase (GDH) catalyzes the reversible forma-
tion of glutamate to α -ketoglutarate46. It has been shown that misexpression of glutamate metabolizing enzymes 
alters postsynaptic iGluR clustering by regulating presynaptic intracellular glutamate concentrations6. Instead of 
directly transporting glutamate, JhI-21 could therefore function to transport metabolites, activators, or suppres-
sors associated with regulation of glutamate levels.
For example, it has been shown that JhI-21 in S2 cells transports leucine, which acts as an allosteric activator of 
the glutamate dehydrogenase (Gdh) and could thereby modify intracellular glutamate levels (Fig. 10)20,47.
Specific role of JhI-21 during late larval development. JhI-21 expression was also previously shown 
to be dependent on Juvenile Hormone (JH)18,19. The role of this hormone in many insects is to maintain juvenile 
morphological characteristics48. In Drosophila, several studies suggested a role for JH in adult behaviors like 
foraging and sexual maturation19,49. The role of JH in larvae, however, remains unclear. In Drosophila larvae, the 
titer of JH III, the active form of JH in Diptera, is high during the first and second larval stages. In feeding stage 
3rd-instar larvae, JH III levels decrease drastically before increasing again during wandering prior to pupation50,51. 
These differences in JH III levels might be responsible for the differences of JhI-21 expression and subcellular 
localization that we observed in this study. This shift in JH III-dependent expression of JhI-21, and the resulting 
shift in postsynaptic sensitivity occurs at the same time as the behavioral switch in late 3rd-instar larvae. When 
placed on agar plate, which is low in nutrients, feeding larvae moved at a higher speed compared to wandering 
individuals. This hypermobility in feeding larvae could reflect aggressive searching for food. Wandering larvae, 
on the other hand, move at a lower pace but turn twice as much compared to feeding larvae (Fig. 7). This behav-
ior could reflect a search for the best place to start pupation. Both behaviors are altered in JhI-21 hypermorphs, 
where feeding and wandering animals move at nearly the same speed and display similar turning rates. Although 
we could demonstrate that JhI-21 is involved in the age dependent shift of synaptic strength between feeding and 
wandering larvae, we can not rule out that other JhI-21 expressing cells in the brain are presumably involved in 
those behavioral changes. In any case, it is nonetheless clear that JhI-21 is important for regulating the change of 
behavior during late 3rd-instar life.
In summary, we show that ERC values can be used to screen for proteins that work in the same neurotrans-
mitter pathway especially when combined with a second screening method such as comparison of expression 
patterns. Using this method, we identified JhI-21 as a novel regulator of synaptic glutamate signaling. We found 
that JhI-21 is expressed in motor neurons where it regulates the developmental specificity of synaptic strength by 
inhibiting the clustering of post-synaptic iGluRs (Fig. 10). We were also able to highlight the role of JhI-21 on late 
larval locomotor activity, and show that changes in the subcellular distribution of JhI-21 within motor neurons 
might explain the differential regulation of JhI-21 on NMJ strength and behavior.
Glutamate is the predominant excitatory neurotransmitter in the central nervous system in mammals. Thus 
glutamate is involved in the control of a wide range of brain functions. It is also a key player in many neurological 
diseases52,53. In this context glutamate transporters play a key role in regulating extracellular glutamate levels to 
maintain dynamic synaptic signaling processes. Therefore our identification of JhI-21 as an important actor on 
glutamatergic and locomotor physiology in Drosophila is suggesting that its possible ortholog (LAT-136) might 
also have an impact on such pathways in mammals. Beside the known glutamate transporters (e.g. vGluTs load-
ing glutamate into synaptic vesicles, and EAATs removing the excess of glutamate by surrounding glial cells)54, 
other transporters such as LAT-1, which are possibly not transporting glutamate could also have a major impact 
on glutamate receptor physiology in the mammalian nervous system. This would be a major clue to explore new 
strategies to cure neurological diseases.
Our data are also highlighting the potential of a new emerging technique in finding genes that co-evolve: ERC. 
This technology proved to be extremely powerful in the recent past to find molecular partners that interact in 
the same cells36. Here we show that it has also the power to decipher specific pathways such as the glutamatergic 
physiology and the age specific control of locomotor activity even if the products of these genes are expressed 
in different cell types (JhI-21 and glutamate receptors). Therefore the ERC technique would be particularly use-
ful to reveal some pluricellular molecular networks such as the interaction between glial cells and neurons, or 
the plasticity of interacting neurons during development or during a learning task by identifying genes that are 
co-evolving. Such applications are facilitated by the ERC analysis webserver that will perform custom analysis 
genome-wide for user-chosen genes55.
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Materials and Methods
Calculation of evolutionary rate covariation statistics. ERC values were calculated as previously 
described36. Briefly, orthologous genes sequences from 12 Drosophila genomes were aligned and used to estimate 
gene-specific branch lengths across the species phylogeny. These branch lengths were transformed into relative 
rates of evolution based on the average genome-wide amount of divergence for each branch10. Rate covariation 
(ERC) values were calculated from the relative rates as a correlation coefficient for each gene pair. Statistical tests 
on groups of genes, such as the glutamate receptors, were performed by comparing the mean ERC value to 10,000 
random sets of the same size using a permutation test.
Drosophila stocks and genetics. Flies were grown and maintained on regular corn medium, at 25 °C, 
in a 12 h/12 h light/dark cycle. Control Drosophila melanogaster used in this study were Oregon-R, P*82 (precise 
excision of P{SUPor-P}JhI-21KG00977; electrophysiology and iGluR quantification), and w1118 (electrophysiology, 
iGluR quantification , and behavior). JhI-21 mutants P{SUPor-P}JhI-21KG00977 (BL12970), PJhI-21EP1187 (not avail-
able any longer at Bloomington, but still available in our laboratory), and Df(2L)esc-P3-0 (BL3131) were pre-
viously characterized29 and obtained from the Bloomington Stock Center. JhI-21 alleles were re-balanced over 
CyO-GFP. P{TubP- Gal4}LL7/TM3, Sb was obtained from Bloomington (BL5138) and re-balanced over TM3GFP, 
Ser. UAS-nSyb-GFP56 provided by B. Hovemann, (Ruhr-University Bochum), repo-Gal4 (BL7415, obtained from 
Bloominton), and 24-B-Gal4 (BL1767, obtained from Bloomington), OK6-Gal4 and OK-371-Gal4 were provided 
by H. Abele (Heinrich-Heine University Düsseldorf). All genotypes used for behavioral experiments were back-
crossed 5 times to an isogenized w1118 fly stock.
JhI-21-Gal4. UAS-Sequences were removed from pUAST attB57 using EcoRI and HindIII. Vector was 
treated with Klenow fragment and religated to make attB. Heat-shock (HS) minimal promotor-, Gal4-, 
and hsp7α olyA-sequence were removed from pCHS-Gal458 using NotI and cloned into attB to make Gal4 
attB. JhI-21 promoter fragment was PCR amplified from genomic DNA of Canton-S flies by using prim-
ers, which introduced KpnI sites for cloning (underlined): GGTACCGGGATTCTTCTGCTTACCCTCT and 
GGTACCGCACCGATAGGAGGATGTATTC. The amplicon was subcloned to pGEM® -T Easy (Promega), 
re-excised and cloned to Gal4 attB using KpnI. The resulting transgenic flies were generated by site-directed inte-
gration using attB44 (provided by J. Bischof, University of Zürich). Injections were performed by Genetic Services 
Inc. (Sudbury, MA, USA).
qPCR for quantification of JhI-21 expression. For reverse transcription RT-PCR, total RNA was iso-
lated using Trizol (Invitrogen, Carlsbad, CA) extraction59. For the JhI-21 expression experiments, total RNA 
was isolated from whole larvae. RNA (500 ng, quantified spectrophotometrically) was reverse transcribed 
using oligo-dT primers and standard methods. 10% of the cDNA product was used to amplify JhI-21 and 
actin5C cDNA fragments by PCR. A 122 fragment of JhI-21 was amplified using the following primer pair: 
TTGTTTACCACGGCGAAATAG and CTTTGTGACGGAGGAGCTACA; a 200 bp fragment of actin5C was 
simultaneously amplified using CAAGCCTCCATTCCCAAGAAC and CGTGAAATCGTCCGTGACATC 
primer pair.
Real-time PCR was performed using an MJResearch Opticon2 real-time thermocycler and quantitative flu-
orescent detection of SYBR green-labeled PCR product. Relative mRNA abundance was calculated using the 
“∆∆CT method”60.
Immunocytochemistry and Confocal microscopy. 2 Rabbit polyclonal anti-JhI-21 antibodies were 
raised against a synthesized peptide (DGEEKIVLKRKLTLINGVA) by Thermo Scientific/Open Biosystems, using 
standard methods and used at a dilution of 1:250. Both gave similar results, and we kept the one giving less back-
ground staining. The JhI-21 peptide epitope represents amino acids 30-48 of the predicted Drosophila JhI-21 
protein. Specificity was verified on JhI-21 null mutant embryos (Figure S2).
NMJs were dissected under Drosophila saline supplied with 2 mM Glutamate. Glutamate present in the 
buffer prevents retraction of glia from the NMJ [4]. Imaging was performed on larval ventral longitudinal mus-
cles (VLM) 6 and 7. For GluRIIA or GluRIIB stainings, NMJs were fixed 30 min in Bouin´s fixative (Sigma). 
Immunostaining measurements of postsynaptic glutamate receptor abundance were performed as previously 
described4,6,31,33,61. For JhI-21 localization experiments, NMJs and larval brains were dissected in PBS + 2 mM 
glutamate (NMJs) or directly in fixative (brains) followed by a 30 min fixation in 4% PFA in PBS. Primary anti-
bodies were incubated overnight at 4 °C. Mouse monoclonal anti-GFP (Sigma Aldrich, Saint Quentin Fallavier, 
France) was used at 1:200. Mouse monoclonal anti-ElaV (9F8A9) was obtained from the University of Iowa 
Developmental Studies Hybridoma Bank (Iowa City, US) and used either at 1:200 or at 1:500. A 1-5 h washing 
step was performed with at least 3 solution changes, before the incubation of secondary antibodies for 2 h at RT 
(for embryos) or overnight at 4 °C (for the rest). DylightTM594-conjugated goat anti-Horseradish Peroxidase 
(HRP) antibody was obtained from Jackson ImmunoReserach Laboratories Inc. (West Grove, US) and used at 
1:500. TRITC-conjugated anti-HRP antibody was obtained from Jackson ImmunoReserach Laboratories Inc. 
(West Grove, US) and used at 1:100. Secondary antibodies (Alexa Fluor 488 or 594 Dye) were obtained from 
Molecular Probes and were diluted at 1:400. Preparations were mounted in Vectashield (H-1000, Vector Labs) 
before imaging using a Leica TCS SP2 AOBS or an Olympus Fluoview FV500 laser scanning confocal system. 
Confocal projections were scanned at 1 μ m section intervals, and were orientated and cropped with LeicaLight 
(also used to obtain Z-projections). Measurements of postsynaptic glutamate receptor density in confocal stacks 
were made by quantifying mean postsynaptic immunofluorescence intensity relative to fluorescence in surround-
ing muscle tissue: F synapse /F background membrane4.
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Electrophysiology. All electrophysiological recordings were obtained at 19 °C from third instar (110-120 hr 
after egg laying) larval ventral longitudinal muscle 6 (A3-A4) at -60 mV holding potential using two-electrode 
voltage clamp technique (TEVC), as previously described4,62,63. Dissections and electrophysiology were per-
formed under glutamate free Drosophila HL-3 saline4. Electrodes for TEVC were filled with 3M KCl yielding 
a resistance of 30–40 MOhm. Spontaneous excitatory junctional currents (sEJCs) or “minis” were detected and 
analyzed using Clampfit9/10 template-matching method that identifies synaptic events based on shape matching 
to a data-based ideal template33. Axon GeneClamp 500B/AxoClamp 900A and Digidata 1550 (Molecular Devices, 
Sunnyvale, CA) were used for data acquisition.
The bathing experiment was performed with 2 mM glutamate during 24 h on NMJ cultures as previously 
described4.
Staging of feeding and wandering LIII larvae. 3rd-instar larvae were picked from the food (to obtain 
feeding stage larvae) or the wall (to obtain wandering stage larvae) of a stock vial and then transferred to a dish 
containing a piece of food for stage confirmation. Animals that stayed in the food were considered as “feeding” 
larvae. Larvae escaping the food were determined to be “wandering” 3rd-instar.
Behavior. Staged larvae were washed in ddH2O before conducting behavioral analysis. Movement analysis 
was performed on a 9 cm-circular 2%-agar-agar medium. This agar medium was used upside down to have a 
perfect flat surface and was placed in the middle of a bigger Pétri dish (13 cm diameter). The space between the 
edge of the Pétri dish and the agar was filled with ddH2O to avoid escaping larvae. A single larva was placed on the 
middle of the agar. Recordings and analysis were performed automatically using EthoVision XT software (Noldus 
information technology, Wageningen, Netherlands). Dynamic subtraction function was chosen to distinguish 
the larva from the background. Data collection was started two minutes after the larva was placed on the agar 
plate. A ten-minute movie was recorded for each individual. Speed and meander behaviors were calculated using 
the same software, since these parameters reflect most of the locomotor activity characteristics of larvae in our 
behavioral set up.
Lethality and Developmental time. Flies were allowed to lay eggs for 20 h. Approximately 3 × 100 
embryos were transferred to fresh vials. 40 h after egg-laying, non-hatched embryos were counted. The amount of 
pupae was determined each day. After 10 days hatched adults were counted and the amount of lethality calculated.
Statistics. All data were transferred to Prism 5.0d (Graphpad) for statistical analysis and tested for normal 
distribution using the D´Agostino and Pearson omnibus normality test. Two pairs of normally distributed data 
were analyzed using the paired-t-test. Pairs of data, which did not pass the normality test, were analyzed using the 
Mann-Whitney test. Three sets of not normally distributed data were analyzed by Kruskal-Wallis test; for quanti-
fication of GluRIIA and GluRIIB we compared both controls with each ‘test’ genotype (i.e. we did 3 comparisons 
for all 5 genotypes). Normally distributed data with two nominal variables were analyzed using the two-way 
ANOVA followed by Bonferroni post test. Survival curves were analyzed using the Chi2 test and cumulative 
frequency histograms by usage of the Kolmogorov-Smirnov test.
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